| Sanofi-Aventis (Suisse) SA - Mutagrip, suspension injectable | | 00373 | | 25 | | Mutagrip | | suspension injectable | | J07BB02 | | Influenza, gereinigtes Antigen | | 18.08.2016 | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (Virus souche A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/HongKong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B) 15 µg, haemagglutininum influenzae B (Virus souche B/Brisbane/60/2008) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0.05 µg, saccharum nihil, neomycinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injektionssuspension | | | | | | Wirkstoffe | Stärke |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus Souche A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-179a) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus Souche A/hongkong/4801/2014 (H3N2)-Like: Reassortant Virus nymc X-263b) | 15 µg | | Haemagglutininum Influenzae b (Virus Souche B/brisbane/60/2008) | 15 µg |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| Dinatrii Phosphas Dihydricus | | | | Formaldehydum | 100 µg | residui | | Kalii Chloridum | | | | Kalii Dihydrogenophosphas | | | | Natrii Chloridum | | | | Neomycinum Nihil | | | | Octoxinolum-9 | 500 µg | | | Ovalbuminum | 0.05 µg | | | Saccharum Nihil | | |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| Es wurden keine Einträge gefunden. |
|
|
